Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency ...Middle East

SAN DIEGO, May 29, 2023 /PRNewswire/ -- Amplo Biotechnology, a leading US-based biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders announced the award of a Fast Track Phase I/II STTR grant from the NIH-NINDS. This highly...

Read More Details
Finally We wish PressBee provided you with enough information of ( Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency )

Also on site :

• Country Legend Dolly Parton Sees Her 'Little Girl Dreams Come True'
• WIN SOURCE Earns Industry Recognition Again, Demonstrates Strength in Global Supply Chain Services
• NYT ‘Connections’ Hints and Answers Today, Tuesday, May 20